IPA was a significant cause of morbidity and mortality among heart and other solid organ transplant recipients.(3) The active infection, including bacterial and fungal infections, particularlyAspergillus infection, raised concerns about the transplant timing.
In this case, the timeline is demonstrated in Figure 5. The decision to proceed with orthotopic heart transplant in the presence of active infection required careful consideration by a multidisciplinary team. During the perioperative and postoperative periods, the team had to weigh the risks and benefits of the transplant simultaneously with an ongoing infection. The decision was well made to minimize the risk of exacerbating the infection or compromising the patient’s post-transplant outcome and the potential consequences of delaying the transplant.